CSIMarket Company Name, Ticker, Suppliers, else..
 
Cingulate Inc   (NASDAQ: CING)
Other Ticker:  
 
 

Cingulate Inc's Customers Performance

CING


 
 
CING's Source of Revenues

• List of CING Customers




for the same period Cingulate Inc

• List of CING Customers





Cingulate Inc's Comment on Sales, Marketing and Customers





  News about Cingulate Inc Contracts

Cingulate's Precision Timed Release Therapy for Anxiety Receives FDA Guidance, Shaping a New Era in Treatment


Introduction
Cingulate Inc., a biopharmaceutical company focused on developing next-generation pharmaceutical products, has announced receiving guidance from the Food and Drug Administration (FDA) on moving forward with its investigational asset CTx-2103 (buspirone) to combat anxiety. This development is a significant step in addressing the growing prevalence of anxiety disorders and improving treatment options for patients.
Understanding Anxiety Disorders
Anxiety disorders are among the most common mental health conditions globally, affecting millions of individuals of all ages. These disorders can significantly impact a person s daily life, leading to distress, impaired productivity, and d...












CING's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Cingulate Inc 5.38 0.00 -15.55 15
SUBTOTAL 0.00 0.00 0.00 -


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright � 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com